The Clinical Trial Equipment & Ancillary Solutions Market Size was valued at USD 2.23 billion in 2023 and is expected to reach USD 4.39 billion by 2032 and grow at a CAGR of 7.84% over the forecast period 2024-2032. This report brings out the rising trend in clinical trial activity and its constant increase due to increased demand for novel treatments and increasing research endeavors. The analysis takes a closer look at geographic differences in the demand for equipment and ancillary solutions, depicting how various markets are coping with changing clinical trial demands. It also examines trends in clinical trial financing and expenditure at the government, commercial, private, and CRO levels, highlighting how money investments are impacting market growth. Trends in regulations and compliance significantly influence market development since changing guidelines affect trial design, equipment standards, and the approval process. The study also evaluates the effects of digitalization and technological innovation, pointing to advancements in trial equipment, automation, and remote monitoring solutions that are transforming the sector.
Drivers
The increasing number of clinical trials globally, rising R&D investments, and advancements in trial methodologies.
The increase in demand for precision medicine, biologics, and cell & gene therapies has created an increased demand for specialized trial equipment and ancillary materials. ClinicalTrials.gov reports that more than 450,000 clinical trials were registered as of 2023, which indicates a robust market demand. The trend towards decentralized and hybrid trials has made the use of remote monitoring devices, digital data collection tools, and direct-to-patient (DTP) logistics solutions more prominent. Also, the increasing trend of outsourcing by pharmaceutical companies to Contract Research Organizations (CROs) is further driving the market since CROs need effective supply chain and equipment solutions. Increased regulatory requirements for temperature-sensitive biologics have also increased the demand for sophisticated cold chain logistics and storage solutions. The use of AI-based clinical trial management systems and blockchain for secure handling of trial data has improved operational efficiency. In addition, the rising number of chronic illnesses such as oncology, cardiology, and neurology is causing an increase in clinical trials, thereby stimulating the demand for trial equipment and ancillary solutions.
Restraints
The market faces several restraints, including high costs of clinical trial equipment and stringent regulatory requirements.
The growing sophistication of international clinical trials necessitates costly real-time monitoring equipment, temperature-controlled storage facilities, and logistics support, which markedly inflate operating expenses. Regulatory compliance with medical devices utilized in clinical trials is also increasingly onerous, resulting in longer approval times and higher compliance expenses. For example, the FDA and EMA have set more stringent requirements for trial equipment validation, which makes it difficult for companies to match changing standards. Inefficiencies are also caused by limited standardization in trial supply chains because different regions have different regulatory needs. In addition, supply chain disruptions, especially caused by global crises like COVID-19 and geopolitical tensions, have affected the timely delivery of trial equipment and ancillary solutions. The lack of adequate professionals with skill sets required to handle sophisticated trial logistics also remains a limitation that slows market growth. Besides this, ethical implications of ensuring data security of the patient as well as using digital technologies for integrating clinical trials raise compliance issues and complicate further market growth.
Opportunities
The rising adoption of decentralized clinical trials (DCTs) and digital transformation presents significant opportunities for market players.
The DCT market will expand at a high growth rate, fueling the need for remote patient monitoring devices. Telehealth solutions and real-time data analytics are also in high demand. The application of AI and machine learning in managing trials is improving data accuracy and trial duration, making it a highly profitable area to invest in. Further, the growth of interest in novel therapy areas such as gene therapy and personalized medicine is fueling demand for sophisticated trial equipment including bioreactors, cryopreservation systems, and molecular diagnostics devices. Increased partnerships between pharmaceutical businesses and technology providers to promote clinical trial efficiency is another huge opportunity. Increased clinical trials in growth markets with inexpensive patient recruitment and quicker regulatory clearance is drawing investments in trial logistics and equipment. In addition, the adoption of blockchain technology within clinical trial supply chains is also on the rise, maintaining data integrity, transparency, and security. Firms that invest in environmentally friendly trial supply solutions, like green packaging and reusable instruments, are likely to also improve their competitive positioning as the industry becomes more environmentally friendly with green clinical trials.
Challenges
The market faces operational and logistical challenges that hinder efficiency and scalability.
A major challenge is real-time visibility in the supply chain since most clinical trials have various global sites that have varying regulatory compliance. Delays in delivering temperature-sensitive medication and trial equipment continue to be a challenge with customs delays, transportation disruptions, and poor cold chain infrastructure in some areas. Another key challenge is equipment maintenance and calibration because clinical trials have high-accuracy instruments that must comply with rigid standards of compliance. The increasing cybersecurity threats in electronic trial management systems also present risks, as patient data security and regulatory compliance have to be ensured at all times. The service provider fragmentation in the clinical trial equipment market creates complexity, with various vendors managing sourcing, logistics, and equipment rental, resulting in inefficiencies. Moreover, site readiness inconsistency and variability in investigator site capabilities delay trial initiation. The reliance on third-party suppliers of clinical trial supplies also poses risks in the supply chain, especially in sudden demand changes or geopolitical conflicts. To counter these issues, firms need to invest in sophisticated supply chain management tools, effective risk mitigation techniques, and integrated trial solutions to increase market resilience.
By Product
The logistics/supply segment dominated with a share of 39.2% in total revenue in 2023. This is because global clinical trials are becoming increasingly complex and need effective supply chain management for on-time delivery of trial machinery, biological samples, and temperature-sensitive products. The increasing uptake of decentralized and hybrid clinical trials has also added to the need for sophisticated logistics solutions such as cold chain storage, direct-to-patient (DTP) delivery models, and real-time tracking systems.
The sourcing segment is projected to see the most robust growth up to 2032, led by growing dependence on expert suppliers for clinical trial hardware and ancillary solutions. Increased outsourcing practices among biotech and pharmaceutical firms, coupled with the emerging trend towards single-vendor supply models, are driving demand at a faster rate. Furthermore, technological improvements in procurement technologies and vendor management systems are optimizing sourcing operations, minimizing costs, and enhancing supply chain resilience.
By Phase
The Phase III segment dominated the market in 2023, with the largest share based on the massive resource needs and extensive patient recruitment of this stage of clinical trials. Being the most important phase prior to regulatory approval, Phase III trials need considerable investments in site management, trial equipment, and logistics. The growing volume of late-stage trials for complex and chronic diseases, including oncology and neurology, further established this segment's market leadership.
The Phase I segment is also expected to develop at the fastest rate during the forecast period due to the growth in early-stage trials, especially in precision medicine, biologics, and gene therapies. The growth in adaptive trial designs and early-phase outsourcing to Contract Research Organizations (CROs) has driven demand for specialty clinical trial equipment and ancillary solutions in this segment. Furthermore, increasing investments in first-in-human trials and fast-track drug development strategies are also driving the growth of Phase I trials further.
North America led the clinical trial equipment & ancillary solutions market in 2023, with a 40.05% revenue share. The leadership of the region is attributed to a well-established pharmaceutical and biotechnology industry, high R&D spending, and a large number of clinical trial activities. Key market players, sophisticated healthcare infrastructure, and encouraging regulatory policies are additional factors driving North America's strong market leadership. The U.S., specifically, is home to the largest share of clinical trials worldwide with streamlined FDA approval processes and the wide-scale adoption of decentralized and hybrid trial models. Furthermore, the rising need for complex logistics, temperature control packaging, and remote monitoring capabilities has further cemented the region's supremacy.
Asia-Pacific is expected to be the fastest-growing region until 2032, led by the growing number of clinical trials, growing pharmaceutical outsourcing, and increasing healthcare infrastructure. China, India, and South Korea are becoming key clinical trial locations because of reduced trial costs, quicker patient recruitment, and government support for R&D investment. The expansion of regional CRO operations, enhanced regulatory convergence, and progress in electronic trial technology further propel the market forward. In addition, Asia-Pacific's escalation in biosimilar and cell & gene therapy studies is also stimulating the requirement for bespoke clinical trial hardware and logistic services.
Ancillare, LP – Clinical Trial Ancillary Supply Chain Solutions, Trial Equipment & Logistics Services
Imperial CRS, Inc. – Ancillary Supplies Management, Trial Logistics & Storage Solutions
Woodley Equipment Company Ltd. – Medical & Laboratory Equipment Rental, Temperature-Controlled Storage Solutions
Thermo Fisher Scientific, Inc. – Clinical Trial Equipment & Lab Instruments, Cold Chain Logistics & Packaging
Parexel International (MA) Corporation – Clinical Trial Supply & Logistics Services, Medical Device & Equipment Management
Emsere (formerly MediCapital Rent) – Clinical Trial Equipment Rental & Leasing, Site-Specific Equipment Solutions
Quipment SAS – Equipment Rental & Calibration Services, Remote Monitoring Devices
IRM (International Resource Management) – Clinical Trial Supply Chain Management, Equipment & Ancillary Solutions
Marken – Clinical Trial Logistics & Distribution, Temperature-Controlled Supply Chain Solutions
Myonex – Clinical Trial Drug & Equipment Supply, Global Site Equipment Management
Yourway – Direct-to-Patient (DTP) Logistics, Clinical Trial Supply Chain & Ancillary Services
In Jan 2025, Ancillare launched its advanced Cold Chain Management services to enhance the safe handling and transport of temperature-sensitive clinical trial supplies. This fully integrated solution ensures optimal product conditions while complying with stringent global regulatory standards.
In March 2024, Myonex announced the acquisition of Creapharm’s Clinical & Commercial Packaging and Bioservices business, expanding its global footprint. The deal includes operations in France (Reims, Bordeaux, Bailly-Romainvilliers) and Marietta, Georgia, USA, strengthening Myonex’s clinical trial supply capabilities.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 2.23 billion |
| Market Size by 2032 | USD 4.39 billion |
| CAGR | CAGR of 7.84% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product [Sourcing (Procurement, Rental), Supply/Logistics (Transportation, Packaging, Others), Service (Calibrations, Equipment servicing, Others), Others] • By Phase [Phase I, Phase II, Phase III, Phase IV] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Ancillare, LP, Imperial CRS, Inc., Woodley Equipment Company Ltd., Thermo Fisher Scientific, Inc., Parexel International (MA) Corporation, Emsere, Quipment SAS, IRM (International Resource Management), Marken, Myonex, Yourway. |
Ans: The Clinical Trial Equipment & Ancillary Solutions market is anticipated to grow at a CAGR of 7.84% from 2024 to 2032.
Ans: The market is expected to reach USD 4.39 billion by 2032, increasing from USD 2.23 billion in 2023.
Ans: The increasing number of clinical trials globally, rising R&D investments, and advancements in trial methodologies.
Ans: The market faces several restraints, including high costs of clinical trial equipment and stringent regulatory requirements.
Ans: North America dominated the Clinical Trial Equipment & Ancillary Solutions market.
Table of content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Clinical Trial Activity – Incidence & Growth (2023)
5.2 Equipment & Ancillary Solutions Demand, by Region (2023)
5.3 Clinical Trial Funding & Spending, by Region (Government, Commercial, Private, CROs) (2023)
5.4 Regulatory & Compliance Trends Affecting Market Growth (2023-2032)
5.5 Digital Transformation & Technological Advancements in Clinical Trial Equipment
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Clinical Trial Equipment & Ancillary Solutions Market Segmentation, by Product
7.2 Sourcing
7.2.1 Sourcing Market Trends Analysis (2020-2032)
7.2.2 Sourcing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Procurement
7.2.3.1 Procurement Market Trends Analysis (2020-2032)
7.2.3.2 Procurement Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Rental
7.2.4.1 Rental Market Trends Analysis (2020-2032)
7.2.4.2 Rental Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Supply/Logistics
7.3.1 Supply/Logistics Market Trends Analysis (2020-2032)
7.3.2 Supply/Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Transportation
7.3.3.1 Transportation Market Trends Analysis (2020-2032)
7.3.3.2 Transportation Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Packaging
7.3.4.1 Packaging Market Trends Analysis (2020-2032)
7.3.4.2 Packaging Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Others
7.3.5.1 Others Market Trends Analysis (2020-2032)
7.3.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Service
7.4.1 Service Market Trends Analysis (2020-2032)
7.4.2 Service Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.3 Calibrations
7.4.3.1 Calibrations Market Trends Analysis (2020-2032)
7.4.3.2 Calibrations Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.4 Equipment servicing
7.4.4.1 Equipment servicing Market Trends Analysis (2020-2032)
7.4.4.2 Equipment servicing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.5 Others
7.4.5.1 Others Market Trends Analysis (2020-2032)
7.4.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Others
7.5.1 Others Market Trends Analysis (2020-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Clinical Trial Equipment & Ancillary Solutions Market Segmentation, by Phase
8.2 Phase I
8.2.1 Phase I Market Trends Analysis (2020-2032)
8.2.2 Phase I Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Phase II
8.3.1 Phase II Market Trends Analysis (2020-2032)
8.3.2 Phase II Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Phase III
8.4.1 Phase III Market Trends Analysis (2020-2032)
8.4.2 Phase III Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Phase IV
8.5.1 Phase IV Market Trends Analysis (2020-2032)
8.5.2 Phase IV Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
10. Company Profiles
10.1 Ancillare, LP
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Imperial CRS, Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Woodley Equipment Company Ltd.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Parexel International (MA) Corporation
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Emsere (formerly MediCapital Rent)
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Quipment SAS
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 IRM (International Resource Management)
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Marken
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Myonex
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product
Sourcing
Procurement
Rental
Supply/Logistics
Transportation
Packaging
Others
Service
Calibrations
Equipment servicing
Others
Others
By Phase
Phase I
Phase II
Phase III
Phase IV
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Animal model Market size was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 8.2%, reaching USD 4.6 billion by 2032.
The Rosacea Treatment Market size was valued at USD 2.07 billion in 2023 and is expected to reach USD 3.70 billion by 2032, growing at a CAGR of 6.64% from 2024 to 2032.
The Smart Drug Delivery Devices Market was valued at USD 9.84 billion in 2023 and is expected to reach USD 34.75 billion by 2032 at 15.07% CAGR from 2024-2032.
The Liver Biopsy Market was valued at USD 0.90 billion in 2023 and is estimated to reach USD 1.65 billion by 2032, growing at a CAGR of 6.99% from 2024 to 2032.
The Intraoral Scanners Market valued USD 0.67 billion in 2023, estimated to reach USD 1.23 Billion By 2032 with a CAGR of 6.99% over the forecast period 2024-2032.
The Compounding Pharmacies Market Size was valued at USD 12.6 Billion in 2023 and will hit USD 19.9 Billion by 2032 with an emerging CAGR of 5.2% Over the Forecast Period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
